Navigation Links
Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients
Date:10/28/2009

y of cancer at the onset of immunosuppressant treatment. When compared to the larger national RA cohort who did not receive TNF inhibitors or have a history of cancer, the relative risk of anti-TNF therapy was 1.00 and remained unchanged for those taking immunosuppressant drugs for up to 6 years. "Our research indicates the overall cancer risk is the same for RA patients on immunosuppressant therapies and those not taking medications for the disease," confirmed Dr. Askling, but adds that "given several remaining uncertainties, continued vigilance remains prudent."


'/>"/>

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. CD200 stifles anti-tumor immunity
2. A new light on the anti-tumor mechanisms of Scutellaria barbata
3. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
4. Short-term stress enhances anti-tumor activity in mice, Stanford study shows
5. Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
6. Popular osteoporosis drugs triple risk of bone necrosis
7. Link between treating osteoporosis with bisphosphonates and incidence of bone necrosis examined
8. Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
9. USC dentist links Fosomax-type drugs to jaw necrosis
10. Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center
11. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... the Clinical Workflow , ... ... using point-of-care resources from EBSCO Publishing ... a new agreement which gives healthcare providers integrated access ... relevant and current information and improved quality care. This ...
(Date:12/7/2009)... , ... Phoenix, AZ (PRWEB) December 7, 2009 ... for spinal cord injury: The online retailer of medical supplies ... products., , ,Cure Medical is a forward-thinking manufacturer of catheters. ... injury, the company donates 10 percent of all of their pre-tax ...
(Date:12/7/2009)... recognized as a leader in the Collection Industry for the ... traditional collection agencies in speed, cost, and customer retention. ... ... A.R.M. Solutions, a leading provider of flat-fee collection services, was ... Collections by insideARM.com. This is the second time this year ...
(Date:12/7/2009)... NEW ORLEANS, Dec. 7 Cell Therapeutics, ... that Ruth Pettengell, M.D. of St. George,s Hospital, ... 2009 American Society of Hematology ("ASH") Annual Meeting ... (PIX 301) clinical trial of pixantrone (the "PIX ... non-Hodgkin,s lymphoma ("NHL") patients who have failed ...
(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Urine test for pediatric obstructive sleep apnea possible 2
... study suggests that where the fat is stored is key ... a person is destined to develop diabetes, experiments in mice ... is stored. , Mice that overate and were very ... hormones let them store extra calories in fat tissue rather ...
... for those over 50 , , THURSDAY, Aug. 23 (HealthDay ... cut the overall risk of bone fractures by about ... of the University of Western Sydney, and colleagues analyzed ... age 50. All of the participants took calcium supplements ...
... with difficulty reading actually respond better to female teachers, ... boys develop higher positive self-perceptions as readers when they ... male research assistants. , The study focused on 175 ... readers by their teachers. The boys participated in a ...
... A compelling new study from the September issue of ... documents and gravesites, suggesting that homosexual civil unions may ... is the latest from the ongoing Contemporary Issues in ... knowledge and current affairs. , Commonly used rationales ...
... Each estimate has its boosters, critics, new articles ... Decades after the last U.S. troops departed Vietnam, ... of that conflict suffered or still suffer from ... is an anxiety disorder involving nightmares, flashbacks and ...
... spotted later, study found , WEDNESDAY, Aug. 22 (HealthDay News) ... more likely than those with private insurance to be diagnosed ... , Each year, about 10,000 men and women in the ... cancer at the time of diagnosis is an important factor ...
Other Medicine News:Health News:Obesity Doesn't Always Equal Diabetes 2Health News:Obesity Doesn't Always Equal Diabetes 3Health News:Daily Calcium Does Protect Bone 2Health News:Are civil unions a 600-year-old tradition? 2Health News:Battle Continues Over Vietnam PTSD Numbers 2Health News:Battle Continues Over Vietnam PTSD Numbers 3Health News:Battle Continues Over Vietnam PTSD Numbers 4Health News:Insurance Impacts Laryngeal Cancer Detection 2
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Amgen Inc. ... three studies on the safety and efficacy of ... (MDS). MDS is a pre-leukemic condition in which ... are unable to mature normally, thereby limiting their ... can lead to low platelet counts. The results ...
(Date:12/4/2009)... A simple, inexpensive computer tool that measures volume ... lungs picked up by a CT scanner can rule ... doctors to diagnose true cancers with fewer, less expensive ... ,, The new diagnostic guidelines are described in a ...
(Date:12/4/2009)... are Transported ,, PHILADELPHIA, Dec. 4 ... American Red Cross are hard at work educating the ... that could potentially put Philadelphia,s blood supply at risk. ... set up a picket line yesterday when their issues ...
Breaking Medicine Technology:Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 1MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 2MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 3Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spe 50419 1Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spe 50419 2Lupin Expands Branded Play 50416 1Lupin Expands Branded Play 50416 2Lupin Expands Branded Play 50416 3
... 7 Taligen Therapeutics Inc.,today announced that in ... were presented at the XXII International Complement Workshop ... in,several animal models of complement-mediated diseases., "These ... studies,presented at the conference, reveal the deep expertise ...
... Planned 15 Patient Cohort Enrolled in Stage A of ... Combination With Carboplatin and Paclitaxel -, TUSTIN, Calif., ... a clinical stage biopharmaceutical,company developing monoclonal antibodies for the ... announced that it has completed,enrollment in the first stage ...
Other Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: